Cargando…

Small cell lung cancer and interstitial pneumonia associated with anti‐transcriptional intermediary factor‐1γ‐positive dermatomyositis

Antibodies to transcriptional intermediary factor‐1γ (TIF‐1γ) are strongly associated with malignancy in patients with dermatomyositis but a relatively low risk for interstitial lung disease. We report the case of a 68‐year‐old female with small cell lung cancer (SCLC) and interstitial pneumonia who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Toshio, Ito, Satoru, Tsuzuki, Toyonori, Watanabe, Daisuke, Kubo, Akihito, Yamaguchi, Etsuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412960/ https://www.ncbi.nlm.nih.gov/pubmed/30906559 http://dx.doi.org/10.1002/rcr2.412

Ejemplares similares

Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
por: Kurushima, Shota, et al.
Publicado: (2017)

SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report
por: Arnon, Johnathan, et al.
Publicado: (2021)

A case of renal cell carcinoma with microscopic pulmonary tumor embolism proven by surgical lung biopsy
por: Katano, Takuma, et al.
Publicado: (2022)

Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
por: Zhang, Suo, et al.
Publicado: (2022)

Autoantibodies to transcription intermediary factor (TIF)1β associated with dermatomyositis
por: Satoh, Minoru, et al.
Publicado: (2012)

Development of dermatomyositis after anti-transcriptional intermediary factor 1-γ antibody seroconversion during treatment for small cell lung cancer
por: Sato, Yuki, et al.
Publicado: (2022)

Anti-transcriptional intermediary factor-1γ antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
por: Kessler, Alaina J., et al.
Publicado: (2023)

Bronchial carcinoid tumor managed with bronchial artery embolization before endobronchial resection: A case report
por: Kajikawa, Shigehisa, et al.
Publicado: (2021)

Lung adenocarcinoma and anti‐transcriptional intermediary factor 1‐gamma positive dermatomyositis complicated with spontaneous oesophageal rupture
por: Saraya, Takeshi, et al.
Publicado: (2019)

The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis
por: Oldroyd, Alexander, et al.
Publicado: (2019)

Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy
por: Aritomi, Takafumi, et al.
Publicado: (2018)

Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
por: Ono, Ryohei, et al.
Publicado: (2021)

Immune checkpoint inhibitor therapy in a patient with small cell lung cancer and anti‐transcriptional intermediary factor 1‐γ antibody‐positive dermatomyositis: A case report
por: Kim, Yoonjoo, et al.
Publicado: (2022)

Comment on: The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody–positive dermatomyositis: Reply
por: Oldroyd, Alexander, et al.
Publicado: (2019)

A Case of Dermatomyositis Along with Esophageal Cancer and Screening of Serum Transcriptional Intermediary Factor 1 Gamma Antibodies in Various Cancer Patients
por: Sumazaki, Makoto, et al.
Publicado: (2020)

Clinically Amyopathic Dermatomyositis with Interstitial Pneumonia That Was Successfully Treated with Plasma Exchange
por: Yagishita, Mizuki, et al.
Publicado: (2018)

Successful Crizotinib Rechallenge after Crizotinib-Induced Organizing Pneumonia in Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
por: Asai, Nobuhiro, et al.
Publicado: (2014)

My-Lupus: A case of anti-transcriptional intermediary factor 1-gamma antibody-positive dermatomyositis overlapping with discoid lupus erythematosus in an adult patient
por: Toker, Michelle, et al.
Publicado: (2023)

Anti-PL-7 antibody-positive dermatomyositis with progressive interstitial pneumonia complicated with tracheal ulcer
por: Sato, Shintaro, et al.
Publicado: (2021)

The Zebrafish moonshine Gene Encodes Transcriptional Intermediary Factor 1γ, an Essential Regulator of Hematopoiesis
por: Ransom, David G, et al.
Publicado: (2004)

Transcriptional Intermediary Factor 1γ binds to the Anaphase-Promoting Complex/Cyclosome and promotes mitosis
por: Sedgwick, Garry G., et al.
Publicado: (2012)

Limitations to the 6-Minute Walk Test in Dermatomyositis with Interstitial Lung Disease in Comparison with Idiopathic Interstitial Pneumonia
por: Someya, Fujiko, et al.
Publicado: (2013)

Bicytopenia in Primary Lung Melanoma Treated with Nivolumab
por: Takahashi, Ayumu, et al.
Publicado: (2018)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Fibrocellular non‐specific interstitial pneumonia with favourable prognosis in clinically amyopathic dermatomyositis
por: Yoshizawa, Takahiro, et al.
Publicado: (2016)

Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
por: Oda, Katsuhiro, et al.
Publicado: (2017)

Successful treatment of thymic carcinoma with dermatomyositis and interstitial pneumonia: A case report
por: Yang, Xingguo, et al.
Publicado: (2019)

Hepatic stellate cell–specific knockout of transcriptional intermediary factor 1γ aggravates liver fibrosis
por: Lee, Eun Ju, et al.
Publicado: (2020)

A case of acute inhalation injury caused by premeditated chlorine gas exposure
por: Katano, Takuma, et al.
Publicado: (2021)

Rapidly progressive interstitial lung disease combined with pneumocystis jiroveci pneumonia in a patient with single anti-TIF-1γ antibody positive dermatomyositis in the context of an underlying tumor
por: Zhang, Hengzhe, et al.
Publicado: (2023)

A Case of Polymyxin b-Immobilized Fiber Column Treatment for Rapidly Progressive Interstitial Pneumonia Associated with Clinically Amyopathic Dermatomyositis
por: Sasaki, Oh, et al.
Publicado: (2013)

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2017)

Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
por: Ikeda, Satoshi, et al.
Publicado: (2015)

Anti-MDA5 Antibody-Positive Interstitial Pneumonia with Autoimmune Features Presenting as Amyopathic Hypodermatitic Dermatomyositis: A Case Report
por: Mihailescu, Maria L., et al.
Publicado: (2021)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

The Intermediary Metabolism of Pyrene
por: Harper, K. H.
Publicado: (1958)

Intermediary metabolism of the lung.
por: Fisher, A B
Publicado: (1984)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report
por: Kishi, Takayuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_udqcbcsopm0ul0ifffaol2p7ts